en.Wedoany.com Reported - On April 2, 2026, a pilot randomized controlled trial showed that an AI virtual assistant designed for patients with heart failure with reduced ejection fraction outperformed the current standard of care in terms of care outcomes. This AI virtual assistant, developed by Eliano Navarese, MD, PhD, a senior scholar at the Carl & Edyth Lindner Research and Education Center within the Christ Hospital Health Network, is the first of its kind.

Dr. Navarese stated that this tool allows patients to receive real-time diagnostic and optimal treatment recommendations without needing to call an on-call physician, which are then approved by an on-call cardiologist. This process provides faster and higher-quality care for both patients and healthcare providers. "This generative AI tool integrates expert physician knowledge directly into primary care," said Dr. Navarese. "Real-time operation helps avoid human errors and ensures the delivery of optimal therapies based on current guidelines. It has the potential to revolutionize care models, especially in rural areas where specialist resources are limited."

Despite advances in cardiovascular care, heart disease remains the leading cause of death for both men and women in the United States. Heart failure, as the primary discharge diagnosis for Medicare, consumes over $35 billion in resources annually. This AI virtual assistant utilizes generative and interactive technologies, distinguishing it from traditional chatbots or algorithms.

Dean Kereiakes, MD, FACC, MSCAI, President of the Christ Hospital Heart & Vascular Institute, stated: "In the context of physician shortages facing the healthcare system, this tool can enhance the quality and efficiency of care. It provides physicians with information and treatment options in real-time based on clinical practice guidelines, helping patients receive optimal treatment faster, thereby improving outcomes. We believe such advanced technology is crucial for addressing current healthcare delivery challenges."

The study has been published in the Journal of the American College of Cardiology (JACC).

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com